Loading page…

Report overview

The report describes ALK's 2008 financial performance, with revenue rising to DKK 1,784 million and 10% organic growth. It highlights breakthrough results for tablet-based allergy vaccination, including long-term GRAZAX results and progress on the house-dust-mite vaccine. The CSR section reports 25,603 MWh of energy consumption, 62,320 m3 of water consumption and 342 ton of waste in 2008.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2008
Period: 1 January 2008 – 31 December 2008
Publication date: 5 February 2009
Language
Pages
File size

Standards & Assurance

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Energy consumption
Water consumption
Waste
Employees

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services